Astrocytoma - Pipeline Review, H2 2011 (Related Reports)

Astrocytoma - Pipeline Review, H2 2011


August 31, 2011
152 Pages - SKU: GMD6506158
License type:
Online Download      US $500.00
Global Site License      US $1,500.00
Neuroblastoma Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
Neuroblastoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2014 provides data on the Neuroblastoma clinical trial scenario. This report provides elemental information and data relating to the  |  read more...
$2,500.00
Tourette Syndrome - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Tourette Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H1 2014’, provides an overview of the Tourette Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tourette  |  read more...
$2,000.00
Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Dementia Associated With Alzheimer's Disease’s therapeutic pipeline. This report  |  read more...
$2,000.00
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Astrocytoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Low-Grade Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Malignant Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014 provides data on the Malignant Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Pontine Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Pontine Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014 provides data on the Pontine Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts
4/2/2014 | published by: GlobalData
MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts Summary The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development  |  read more...
$6,495.00
Narcolepsy - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Narcolepsy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Narcolepsy - Pipeline Review, H1 2014’, provides an overview of the Narcolepsy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Narcolepsy, complete with comparative  |  read more...
$2,000.00
Investigation Report on China Aripiprazole Market, 2009-2018
3/6/2014 | published by: China Research and Intelligence Co., Ltd.
Investigation Report on China Aripiprazole Market, 2009-2018 Schizophrenia is a common mental disorder. Data shows that mental illness has exceeded cardiovascular system, respiratory diseases and malignant tumors and turns into the heaviest social burden. Statistics shows  |  read more...
$1,800.00